Few fields in medicine are as promising and complex as gene therapy. As researchers race to develop cures for previously ...

Across all DME patients dosed to date, 4D-150 continues to be well tolerated with no intraocular inflammation observed at any timepoint or dose ...

Terremoto Biosciences, a biotechnology company developing first- and best-in-class targeted therapeutics, today announced the appointment of James Christensen, Ph.D., as President and Head of Research ...

Pulse Biosciences, Inc. (the "Company" or "Pulse Biosciences"), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablationtm (nano-PFA or nsPFAtm) technology, today announced the ...

Stanford Medicine physicians have a new artificial intelligence tool to assist them when they message patients about test ...

Doctors have an overwhelming amount of individual patient data and medical research at their disposal to make diagnoses and ...

Cervical cancer remains a major health threat for women globally, with the highest incidence in developing nations. Despite ...

Across the United States, no hospital is the same. Equipment, staffing, technical capabilities, and patient populations can all differ.

AI was intended to save patients cost in health care. However, experts say it's costlier than expected because humans need to help monitor it.

Venture capital investment in healthcare increased to $23 billion in 2024, up from $20 billion in 2023, fueled by the rapid adoption of AI technologies, a Jan. 8 report from Silicon Valley Bank found.